Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Vertex Pharmaceuticals
(NQ:
VRTX
)
401.08
+0.92 (+0.23%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Vertex Pharmaceuticals
< Previous
1
2
3
4
5
6
Next >
Vertex and CRISPR Therapeutics Present New Data in 22 Patients With Greater Than 3 Months Follow-Up Post-Treatment With Investigational CRISPR/Cas9 Gene-Editing Therapy, CTX001™ at European Hematology Association Annual Meeting
June 11, 2021
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
Vertex Announces Primary Endpoint Achieved in Phase 2 Study of VX-864 in Alpha-1 Antitrypsin Deficiency
June 10, 2021
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
CORRECTING and REPLACING Vertex Announces U.S. FDA Approval for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in Children With Cystic Fibrosis Ages 6 through 11 With Certain Mutations
June 09, 2021
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
Vertex Announces U.S. FDA Approval for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in Children With Cystic Fibrosis Ages 6 through 11 With Certain Mutations
June 09, 2021
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
Vertex to Present at the Bank of America Securities 2021 Virtual Health Care Conference on May 13
May 10, 2021
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
Vertex Reports First-Quarter 2021 Financial Results
April 29, 2021
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
Vertex and Obsidian Therapeutics Establish Collaboration to Discover Novel Therapies That Regulate Gene Editing
April 22, 2021
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
Vertex to Announce First-Quarter 2021 Financial Results on April 29
April 19, 2021
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.